Company · CIK 1815974
Anebulo Pharmaceuticals, Inc.
| CIK | 1815974 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | ANEB (OTC) |
| First annual or quarterly report | 2021-06-21 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-268113 | 2022-11-02 | 2025-09-23 | 3 | |
| 333-285098 | 2025-02-20 | 2025-09-23 | 4 | |
| 333-254979 | 2021-04-01 | 2021-05-10 | 5 |
Filings
13| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-09-23 | EFFECTDeclared effective | 333-285098 | 9999999995-25-003064 |
| 2025-09-23 | EFFECTDeclared effective | 333-268113 | 9999999995-25-003060 |
| 2025-03-03 | 424B5Shelf takedown | 333-285098 | 0001493152-25-008861 |
| 2025-02-28 | EFFECTDeclared effective | 333-285098 | 9999999995-25-000562 |
| 2025-02-20 | S-3Shelf registered | 333-285098 | 0001493152-25-007755 |
| 2022-11-10 | EFFECTDeclared effective | 333-268113 | 9999999995-22-003277 |
| 2022-11-02 | S-1Registration filed | 333-268113 | 0001493152-22-030199 |
| 2021-05-10 | 424B4Final prospectus | 333-254979 | 0001493152-21-010889 |
| 2021-05-06 | EFFECTDeclared effective | 333-254979 | 9999999995-21-001821 |
| 2021-05-05 | S-1/AAmendment | 333-254979 | 0001493152-21-010495 |
| 2021-04-26 | S-1/AAmendment | 333-254979 | 0001493152-21-009689 |
| 2021-04-01 | S-1Registration filed | 333-254979 | 0001493152-21-007758 |
| 2021-01-29 | DRSDraft made public | 377-04121 | 0001493152-21-002099 |